The US regulator has reported a sharp rise in expected savings after completing its second round of Medicare drug price ...
Chinese biotech companies are pivoting from "fast-follow" to "smart" first-in-class (FIC) innovation, a shift that is ...
The American medicines regulator has approved a reformulated version of ranitidine from USA-based VKT Pharma, restoring the ...
India’s Sun Pharmaceutical Industries today announced the US Food and Drug Administration (FDA) approved an updated label for ...
Shares of Las Vegas, USA-based PharmaCyte Biotech rose 25% by close yesterday, after it announced the successful monetization ...
The US Food and Drug Administration approved AstraZeneca’s Imfinzi (durvalumab) with fluorouracil, leucovorin, oxaliplatin, ...
Chinese biotech Akeso (HKEX: 9926) has secured Breakthrough Therapy Designation for Idafang (ivonescimab) in triple-negative ...
Neurizon has appointed Justine Conway, global head of business development at US animal-health group Elanco (NYSE: ELAN), as ...
The US Food and Drug Administration (FDA) has granted accelerated approval of Voyxact (sibeprenlimab-szsi) for the reduction ...
In a show of rare bipartisan agreement in the US Congress, lawmakers raised concerns over how the 340B program is driving up ...
Cantor Fitzgerald analysts have connected with Danish biotech Ascendis Pharma’s on the three-month Prescription Drug User Fee Act (PDUFA) extension of TransCon hGH) CNP (navepegritide) for ...
UK pharma major GSK has announced that the National Institute for Health and Care Excellence (NICE) has issued final guidance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback